Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials

NCT06548139 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Rabies Virus Infection

Interventions

DRUG: Natural full human monoclonal antibody CBB 1 injection 50.0µg/kg
DRUG: Natural full human monoclonal antibody CBB 1 injection 100.0µg/kg
DRUG: Rabies Human Immunoglobulin (HRIG)
BIOLOGICAL: Lyophilized rabies vaccine for human use (Vero cells)

Sponsor

Changchun BCHT Biotechnology Co.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]